Celebrex in treatment of joint diseases in patients with risk factors of gastropathy and cardiovascular palhalodydevelopment
Literature digest is presented concerning to gastrointestinal and cardiovascular safety of selective COX- 2 inhibitors including results of Russian clinico-endoscopic study of celebrex efficacy and tolerability in osteoarthritis (OA). Celebrex was administered to the pts with risk factors of gastroi...
Saved in:
Main Authors: | N. V. Chichasova, G R Imametdinova, E L Nassonov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA PRESS LLC
2004-02-01
|
Series: | Научно-практическая ревматология |
Subjects: | |
Online Access: | https://rsp.mediar-press.net/rsp/article/view/1234 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CELEBREX IN TREATMENT OF VERTEBRAL PAIN SYNDROME IN SYSTEMICV LUPUS ERYTHEMATOSUS
by: N. P. Shilkina, et al.
Published: (2002-06-01) -
Total knee and hip replacement in rheumatoid arthritis: A current trend
by: V. N. Khlaboshchina, et al.
Published: (2024-04-01) -
Melox (meloxicam) clinical efficacy in chronic joint diseases
by: Sh Erdes, et al.
Published: (2003-08-01) -
RISK FACTORS FOR OSTEOPOROSIS IN PATIENTS WITH RHEUMATOID ARTHRITIS
by: E. A. Taskina, et al.
Published: (2014-10-01) -
CELEBREX IN TREATMENT OF VERTEBRAL PAIN SYNDROME IN SYSTEMICV LUPUS ERYTHEMATOSUS
by: N. P. Shilkina
Published: (2002-06-01)